Global Peanut Allergy Vaccine Market Analysis
Food
allergies are becoming more common these days. Among the most common allergens
are milk, protein, and shellfish. Another common allergen is peanut.
Peanut
allergy can cause a variety of allergic reactions, including anaphylaxis. There
is currently no treatment available for peanut allergy. Some of the
experimental drugs are preferred for the treatment of peanut allergies. The
Food and Drug Administration (FDA) is expected to approve two or more
immunotherapy drugs for the treatment of peanut allergies.
Peanut
allergy is also a leading cause of death. Although there is evidence that
peanut oral immunotherapy reduces the severity of the allergy, such methods
require proper intervention.
The peanut allergy vaccine market is predicted to grow significantly within the near
future. Peanut allergy vaccine is given to patients who are identified as
having a high risk of developing peanut allergy to stop future allergies
like anaphylaxis.
According to
a report published by the National Centre for Biotechnology Information,
allergy to peanuts and tree nuts (TNs) is that the leading explanation for
fatal allergies within us, and therefore the number of cases appears to be
increasing. Over 1% (approximately 3 million) of individuals reported peanut or
tree nut allergies during this 11-year follow-up study, and therefore the condition
has been on the increase, primarily among children.
Due to the
introduction of latest products within the industry, the worldwide peanut
allergy treatment market is expected to grow rapidly within the near future
These products are anticipated to be in high demand within the market.
Alternatively,
a rise within the number of patient visits to clinics for the treatment of this
allergy, also as a rise in commercial and scientific activities for R&D,
are expected to drive the worldwide peanut allergy treatment market during the
forecast period.
By end-user global peanut allergy vaccine market is segmented as
follows:
- Personal Clinics
- Hospitals
- Gov Agencies
- Medical Practitioners
In the
current Peanut allergy vaccine market scenario, companies are focusing on
obtaining regulatory approval for their products from the appropriate
regulatory bodies. Allergy Therapeutics, Zicam, Aravax, Immunomic Therapeutics,
Inc., Astellas, and Aimmune are the major players in the market.
The peanut
allergy treatment market in Europe and the Asia Pacific is expected to grow
significantly during the forecast period, owing to an increase in the number of
food-related allergy tests and per-capita healthcare spending.
Market Size of the Global Peanut
Allergy Treatment Market by Drug Type:
- Epinephrine Injection (EpiPen, Twinject, AUVI-Q)
- Antihistamines
Market Size of the Global Peanut
Allergy Treatment Market by Distribution Channel:
- Pharmacies for the general public
- Pharmacy Services in Hospitals
- Online Drugstores
- Pharmacies
Regional Market for Peanut Allergy
Treatment:
- Asia Pacific
- Europe
- North America
- Latin America
- Middle East and Africa


Comments
Post a Comment